Authors
  • Dr. Gregory Albers has been the Director of the Stanford Stroke Center since its inception in 1992. He joined the Stanford University Medical Center in 1988 and has served as Professor of Neurology and Neurological Sciences since 1999. Dr. Albers is a leader in the clinical care of stroke patients as well as cerebrovascular research and education. Dr. Albers has published more than 375 articles in the medical literature and has been the principal investigator of more than 60 clinical studies. Dr. Albers has chaired multiple consensus panels that have published national and international guidelines for stroke treatment and prevention. Under his guidance, the Stanford Stroke Center has trained more than 30 clinical stroke specialists; many of whom are directing stroke centers at academic institutions throughout the country. Dr. Albers’ current research focus is the use of advanced imaging techniques to expand the treatment window for thrombectomy as well as administration of intravenous thrombolytic therapy. He is currently leading a National Institutes of Health-funded multi-center clinical trial investigating the role CT perfusion and MR perfusion in identifying patients who are most likely to benefit from stroke therapies. Dr. Albers was instrumental in the development of RAPID, a software platform that interprets brain scans and helps clinicians decide on appropriate treatments for ischemic stroke. Dr. Albers earned his MD at the University of California, San Diego in 1984 and completed his Internship, Residency and Fellowship at the Stanford University Medical Center. 

     

  • Dr. Maarten Lansberg completed his neurology training at the University of California San Francisco (UCSF) and his neurovascular fellowship at Stanford University. Following fellowship, he joined the faculty of the Department of Neurology at Stanford where he is currently an Associate Professor. Dr Lansberg’s research interest is in the design and conduct of clinical trials to test new methods for diagnosing and treating stroke patients. He has been an investigator on dozens of stroke trials. The primary focus of his research has been on the use of modern imaging techniques for the evaluation of acute stroke. These techniques include diffusion-weighted MRI, perfusion-weighted MRI and CT perfusion. Dr. Lansberg played a lead role in the recently completed DEFUSE 3 trial, which demonstrated that patients selected with MR or CT perfusion imaging benefit from endovascular stroke therapy up to 16 hours after onset. Dr Lansberg is also the lead investigator on several stroke recovery trials.